| # | Drug | Count |
|---|---|---|
| 0 | ABACAVIR | 5 |
| 1 | ABACAVIR SULFATE | 5 |
| 2 | ATAZANAVIR | 5 |
| 3 | EMTRICITABINE | 5 |
| 4 | LAMIVUDINE | 5 |
| 5 | LAMIVUDINE ORAL | 5 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE | 3 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR SULFATE | 5 | 0.0005 |
| 1 | ATAZANAVIR | 5 | 0.0003 |
| 2 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 3 | 0.0003 |
| 3 | LAMIVUDINE | 5 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |